BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 21752404)

  • 1. [Evaluation of liver fibrosis by non-invasive methods].
    Tor J; Muga R
    Med Clin (Barc); 2011 Nov; 137(14):642-4. PubMed ID: 21752404
    [No Abstract]   [Full Text] [Related]  

  • 2. Transient Elastography May Improve Detection of Liver Fibrosis in Psoriasis Patients Treated with Methotrexate.
    Talme T; Nikamo P; Rosenberg P; Ståhle M
    Acta Derm Venereol; 2017 Aug; 97(8):952-954. PubMed ID: 28422266
    [No Abstract]   [Full Text] [Related]  

  • 3. Practice gaps. Methotrexate-induced liver toxicity: replacing the liver biopsy.
    Strober BE
    JAMA Dermatol; 2014 Aug; 150(8):862-3. PubMed ID: 24965863
    [No Abstract]   [Full Text] [Related]  

  • 4. Evaluation of liver fibrosis by transient elastography in methotrexate treated patients.
    Barbero-Villares A; Mendoza J; Trapero-Marugan M; Gonzalez-Alvaro I; Daudén E; Gisbert JP; Moreno-Otero R
    Med Clin (Barc); 2011 Nov; 137(14):637-9. PubMed ID: 21719043
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The use of transient elastography and FibroTest for monitoring hepatotoxicity in patients receiving methotrexate for psoriasis.
    Lynch M; Higgins E; McCormick PA; Kirby B; Nolan N; Rogers S; Lally A; Vellinga A; Omar H; Collins P
    JAMA Dermatol; 2014 Aug; 150(8):856-62. PubMed ID: 24964792
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluation of liver fibrosis by transient elastography (Fibroscan®) in patients with inflammatory bowel disease treated with methotrexate: a multicentric trial.
    Barbero-Villares A; Mendoza Jiménez-Ridruejo J; Taxonera C; López-Sanromán A; Pajares R; Bermejo F; Pérez-Calle JL; Mendoza JL; Algaba A; Moreno-Otero R; Maté J; Gisbert JP;
    Scand J Gastroenterol; 2012 May; 47(5):575-9. PubMed ID: 22229701
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Psoriasis, transient elastography and methotrexate: monitoring at a tertiary hospital.
    Koch K
    Australas J Dermatol; 2021 Feb; 62(1):69-70. PubMed ID: 32700316
    [No Abstract]   [Full Text] [Related]  

  • 8. Hepatoprotective effect of tumour necrosis factor alpha blockade in psoriatic arthritis: a cross-sectional study.
    Seitz M; Reichenbach S; Möller B; Zwahlen M; Villiger PM; Dufour JF
    Ann Rheum Dis; 2010 Jun; 69(6):1148-50. PubMed ID: 19854710
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Advanced liver fibrosis secondary to methotrexate treatment].
    Polo Romero FJ; Blasco Colmenarejo MM; Tirado Miranda R; Navarro Martínez A
    Gastroenterol Hepatol; 2003 Nov; 26(9):617-8. PubMed ID: 14642249
    [No Abstract]   [Full Text] [Related]  

  • 10. Compensated heart failure does not always alleviate overestimation of liver stiffness by transient elastography.
    Park Y; Kim SU; Koh MJ; Lee S
    Eur J Gastroenterol Hepatol; 2013 Mar; 25(3):385-7. PubMed ID: 23348020
    [No Abstract]   [Full Text] [Related]  

  • 11. Comment on: Liver fibrosis in patients with psoriasis and psoriatic arthritis on long-term, high cumulative dose methotrexate therapy.
    Boffa MJ; Smith A; Chalmers RJ
    Rheumatology (Oxford); 2009 Nov; 48(11):1464; author reply 1465. PubMed ID: 19671697
    [No Abstract]   [Full Text] [Related]  

  • 12. The role of real-time elastography in the evaluation of post chemotherapy hepatotoxicity in children with cancer.
    Mărginean CO; Baghiu MD; Branzaniuc K; Chinceşan M; Adrienne H; Buzoianu A; Mărginean C
    Rev Med Chir Soc Med Nat Iasi; 2011; 115(1):70-7. PubMed ID: 21682186
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Risk of liver injury among methotrexate users: A meta-analysis of randomised controlled trials.
    Conway R; Low C; Coughlan RJ; O'Donnell MJ; Carey JJ
    Semin Arthritis Rheum; 2015 Oct; 45(2):156-62. PubMed ID: 26088004
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Magnetic resonance elastography and transient elastography as non-invasive analyses for liver fibrosis: can they obviate the need for liver biopsy in psoriasis patients treated with methotrexate?
    Kaffenberger BH; Kaffenberger JA; Wong H; Jarjour W; Levin D; Bechtel MA
    Int J Dermatol; 2015 Jul; 54(7):752-6. PubMed ID: 26108262
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Epstein Barr virus-induced hepatitis associated with methotrexate treatment.
    Lapalus MG; Hot A; Fontana A; Guillaud O; Miossec P; Scoazec JY; Dumortier J
    J Clin Gastroenterol; 2008 Feb; 42(2):217-9. PubMed ID: 18209599
    [No Abstract]   [Full Text] [Related]  

  • 16. Analysis of risk factors in psoriatic patients with methotrexate-induced increases in transaminase levels.
    Heydendael VM; Spuls PI; Bossuyt PM; Bos JD; de Rie MA
    Arch Dermatol; 2004 Oct; 140(10):1289-90. PubMed ID: 15492205
    [No Abstract]   [Full Text] [Related]  

  • 17. Psoriatic arthritis, methotrexate and the liver--are rheumatologists putting their patients at risk?
    Lindsay K; Gough A
    Rheumatology (Oxford); 2008 Jul; 47(7):939-41. PubMed ID: 18474510
    [No Abstract]   [Full Text] [Related]  

  • 18. The challenge of non-invasive evaluation of fibrosis after liver transplantation.
    Conti F
    Clin Res Hepatol Gastroenterol; 2013 Sep; 37(4):314-5. PubMed ID: 23622711
    [No Abstract]   [Full Text] [Related]  

  • 19. Liver fibrosis screening for patients with psoriasis taking methotrexate: a cross-sectional study comparing transient elastography and liver biopsy.
    Bray AP; Barnova I; Przemioslo R; Kennedy CT
    Br J Dermatol; 2012 May; 166(5):1125-7. PubMed ID: 21967341
    [No Abstract]   [Full Text] [Related]  

  • 20. [Methotrexate].
    Rau R
    Z Rheumatol; 2016 Aug; 75(6):599-603. PubMed ID: 27365027
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.